Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

Persky, Daniel O

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 2008 - 2258-63 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

1527-7755

10.1200/JCO.2007.13.6929 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Female
Humans
Lymphoma, B-Cell--drug therapy
Male
Middle Aged
Neoplasm Staging
Prednisone--administration & dosage
Rituximab
Vincristine--administration & dosage